dostęp otwarty

Ahead of print
ORIGINAL PAPERS
Opublikowany online: 2017-11-24
Pobierz cytowanie

Plasma concentration of tryptophan and pregnancy-induced hypertension

Agnieszka Grafka, Maciej Łopucki, Katarzyna Karwasik-Kajszczarek, Marzena Stasiak-Kosarzycka, Grzegorz Dzida
DOI: 10.5603/AH.a2017.0024

dostęp otwarty

Ahead of print
ORIGINAL PAPERS
Opublikowany online: 2017-11-24

Streszczenie

Introduction. Pregnancy-induced hypertension (PIH) is one of the main clinical problems of unexplained etiopathogenesis. New factors involved in the pathogenesis of this disease are still being searched. The available literature lacks data regarding the differences in tryptophan concentrations in physiological and PIH-complicated pregnancy. Previous studies have shown that L-tryptophan treatment reduces blood pressure in hypertensive rats. The direct vascular effects of tryptophan have not been fully explored. In this study, the stimulating effect of tryptophan on the development of PIH was revealed. The aim of the present study was to assess the differences in plasma tryptophan concentrations in physiological pregnancies and pregnancies complicated with hypertension in the third trimester. Material and methods. The study was carried on 105 complicated by PIH and 105 pregnant women with blood pressure within normal limits between 25 and 41 weeks of gestation. Tryptophan concentration was determined by the automated ion-exchange chromatography using an Amino Acid Analyser (AAA 400) by Ingos, Czech Republic. Tryptophan concentration was expressed in μmol/cm3 plasma. Results. The mean concentration of tryptophan in the third trimester of physiological pregnancy was found to be 0.035 ± 0.009 μmol/cm3, whereas in PIH — 0.099 ± 0.007 μmol/cm3. Conclusions. The development of PIH in pregnant women is likely to be caused by increased concentrations of tryptophan, which is a substrate for production of serotonin and tryptamine. Further studies are needed to analyse the kinetics of tryptophan metabolism.

Streszczenie

Introduction. Pregnancy-induced hypertension (PIH) is one of the main clinical problems of unexplained etiopathogenesis. New factors involved in the pathogenesis of this disease are still being searched. The available literature lacks data regarding the differences in tryptophan concentrations in physiological and PIH-complicated pregnancy. Previous studies have shown that L-tryptophan treatment reduces blood pressure in hypertensive rats. The direct vascular effects of tryptophan have not been fully explored. In this study, the stimulating effect of tryptophan on the development of PIH was revealed. The aim of the present study was to assess the differences in plasma tryptophan concentrations in physiological pregnancies and pregnancies complicated with hypertension in the third trimester. Material and methods. The study was carried on 105 complicated by PIH and 105 pregnant women with blood pressure within normal limits between 25 and 41 weeks of gestation. Tryptophan concentration was determined by the automated ion-exchange chromatography using an Amino Acid Analyser (AAA 400) by Ingos, Czech Republic. Tryptophan concentration was expressed in μmol/cm3 plasma. Results. The mean concentration of tryptophan in the third trimester of physiological pregnancy was found to be 0.035 ± 0.009 μmol/cm3, whereas in PIH — 0.099 ± 0.007 μmol/cm3. Conclusions. The development of PIH in pregnant women is likely to be caused by increased concentrations of tryptophan, which is a substrate for production of serotonin and tryptamine. Further studies are needed to analyse the kinetics of tryptophan metabolism.
Pobierz cytowanie

Słowa kluczowe

tryptophan, pregnant women, hypertension, blood plasma

Informacje o artykule
Tytuł

Plasma concentration of tryptophan and pregnancy-induced hypertension

Czasopismo

Arterial Hypertension

Numer

Ahead of print

Data publikacji on-line

2017-11-24

DOI

10.5603/AH.a2017.0024

Słowa kluczowe

tryptophan
pregnant women
hypertension
blood plasma

Autorzy

Agnieszka Grafka
Maciej Łopucki
Katarzyna Karwasik-Kajszczarek
Marzena Stasiak-Kosarzycka
Grzegorz Dzida

Ważne: serwis https://journals.viamedica.pl/ wykorzystuje pliki cookies. Więcej >>

Używamy informacji zapisanych za pomocą plików cookies m.in. w celach statystycznych, dostosowania serwisu do potrzeb użytkownika (np. język interfejsu) i do obsługi logowania użytkowników. W ustawieniach przeglądarki internetowej można zmienić opcje dotyczące cookies. Korzystanie z serwisu bez zmiany ustawień dotyczących cookies oznacza, że będą one zapisane w pamięci komputera. Więcej informacji można znaleźć w naszej Polityce prywatności.

Czym są i do czego służą pliki cookie możesz dowiedzieć się na stronie wszystkoociasteczkach.pl.

Czasopismo Nadciśnienie Tętnicze dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl